The investment, which includes Varian’s Ethos adaptive radiotherapy system, is part of Prisma Health’s long-term partnership with Siemens Healthineers.
Prisma Health, based in Greenville, SC, is expanding its value partnership with Siemens Healthineers through a $50 million investment in radiation therapy technology.
Prisma Health’s investment includes the acquisition of the Ethos adaptive radiotherapy system from Varian, a Siemens Healthineers company. Adaptive radiotherapy is designed to provide cancer patients with more precise and personalized care through AI-driven treatment and planning processes that adapt to tumor and anatomical changes in real time to protect healthy tissue.
In 2021, Siemens Healthineers and Prisma Health entered into a 10-year value partnership to improve care, promote innovation, and develop the local workforce. The expanded relationship will integrate next-generation technology and specialized clinical oncology and professional services, new tools, and time-saving workflows. The goal of the partnership is to advance more personalized, efficient, and accessible care for the communities Prisma Health serves.
“Our priority is ensuring that patients have access to care that is both compassionate and informed by the latest clinical insights,” says Clarence Sevillian, executive vice president and chief operating officer of Prisma Health, in a release. “This next phase of the partnership reflects a continued spirit of collaboration, integrating advanced oncology tools and support services that may help streamline operations and enhance the patient experience.”
John Kowal, president and head of the Americas at Siemens Healthineers, adds in a release, “Working with Prisma Health to establish a full continuum of cancer care—from screening and diagnosis through survivorship—is an enormous point of pride for our organization. Combining the power of diagnostic imaging, radiation therapy, and post-treatment monitoring with professional services to manage complex oncology operations helps to ensure that advances in patient care are consistent and sustainable over time.”
Photo caption: Varian’s Ethos radiotherapy systems
Photo credit: PRNewswire/Varian
